Carrie Renee Graveel - Publications
Affiliations: | 2002 | University of Wisconsin, Madison, Madison, WI |
Year | Citation | Score | |||
---|---|---|---|---|---|
2003 | Graveel CR, Harkins-Perry SR, Acevedo LG, Farnham PJ. Identification and characterization of CRG-L2, a new marker for liver tumor development. Oncogene. 22: 1730-6. PMID 12642876 DOI: 10.1038/Sj.Onc.1206309 | 0.527 | |||
2002 | Wells J, Graveel CR, Bartley SM, Madore SJ, Farnham PJ. The identification of E2F1-specific target genes. Proceedings of the National Academy of Sciences of the United States of America. 99: 3890-5. PMID 11904439 DOI: 10.1073/Pnas.062047499 | 0.569 | |||
2001 | Graveel CR, Jatkoe T, Madore SJ, Holt AL, Farnham PJ. Expression profiling and identification of novel genes in hepatocellular carcinomas. Oncogene. 20: 2704-12. PMID 11420682 DOI: 10.1038/Sj.Onc.1204391 | 0.692 | |||
2001 | Graveel C, Jatkoe T, Madore S, Holt A, Farnham P. Analysis of gene expression alterations in mouse and human hepatocellular carcinomas Nature Genetics. 27: 57-57. DOI: 10.1038/87102 | 0.69 | |||
2001 | Farnham P, Graveel C, Kirmizis A, Bartley S, Kel A, Kel-Margoulis O, Wingender E, Zhang M, Jatkoe T, Madore S. Use of chromatin immunoprecipitation to study transcriptional deregulation in cancer cells Nature Genetics. 27: 53-53. DOI: 10.1038/87076 | 0.574 | |||
1999 | Lukas ER, Bartley SM, Graveel CR, Diaz ZM, Dyson N, Harlow E, Yamasaki L, Farnham PJ. No effect of loss of E2F1 on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice. Molecular Carcinogenesis. 25: 295-303. PMID 10449036 DOI: 10.1002/(Sici)1098-2744(199908)25:4<295::Aid-Mc8>3.0.Co;2-9 | 0.63 | |||
Show low-probability matches. |